Status:
COMPLETED
Tranexamic Acid in Pregnant Women Undergoing Cesarean Section.
Lead Sponsor:
Aswan University Hospital
Conditions:
Cesarean Section Complications
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Purpose to evaluate the effects of topical tranexamic acid (TA) on reducing post-partum hemorrhage in pregnant women with hemorrhagic cesarean section
Detailed Description
Uterine atony is the major cause of postpartum hemorrhage (PPH), accounting for up to 80% of PPH cases. PPH is the leading cause of maternal morbidity and mortality worldwide, resulting in up to 28% o...
Eligibility Criteria
Inclusion
- patients who were admitted for an elective or non-emergency CS during labor and exposed to intraoperative bleeding about 800 ml
Exclusion
- placenta praevia and placental abruption
- Women with a medical disorder,
- placenta accrete,
- allergy to TA, and
- intraoperative bleeding thanks to causes aside from uterine atony
- Patients over 40 or who have
- pre-existing coagulation disorders,
- with a severe medical disorder
- allergy to tranexamic acid
- refuse to consent
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03778242
Start Date
January 1 2019
End Date
July 1 2022
Last Update
April 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University
Aswān, Egypt, 81528